首页> 美国卫生研究院文献>Clinical Orthopaedics and Related Research >Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Non-oncologic Conditions After Distal Femur Replacement?
【2h】

Does a Competing Risk Analysis Show Differences in the Cumulative Incidence of Revision Surgery Between Patients with Oncologic and Non-oncologic Conditions After Distal Femur Replacement?

机译:竞争风险分析是否显示了在远端股骨替代后肿瘤和非肿瘤病症患者患者修复手术的累积发生率的差异?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Distal femur replacement is frequently used for limb salvage after bone tumor resections. It is also used in patients with severe bone loss because of traumatic conditions or revision TKA. Some studies on distal femur replacement reported on revision-free survival without distinguishing between patients with oncologic diagnoses and those without, although these patients might be incomparable because of their differences in important patient- and disease-specific characteristics. This may lead to an inaccurate and undifferentiated interpretation of the results of survival analyses.
机译:远端股骨置换通常用于骨肿瘤切除后的肢体挽损。它也用于严重骨质损失的患者,因为创伤条件或修正TKA。一些关于无视线存活的远端股骨替代的研究,而不区分肿瘤学诊断的患者,尽管这些患者可能是无与伦比的,因为它们对重要患者和疾病特异性特征的差异。这可能导致对生存分析结果的不准确和未分化的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号